FDA
approval
· 2023-06-21
FDA Approved: FINZALA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for FINZALA, a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FINZALA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)